BioBridgeXAll companies

Acrigen Biosciences, Inc.

Biotechnology company · Kensington, California, United States

Acrigen Biosciences, Inc. is a biotechnology company headquartered in Kensington, California, United States. Its earliest recorded incorporation is in 2019. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $765,291 in total, most recently in 2022. It has reported private securities offerings to the US SEC, most recently $775,000 sold in a notice filed in 2019.

www.acrigen.comProfile compiled from public records. Is this your company? Request a correction or update

Acrigen Biosciences at a glance

Typebiotechnology company
HeadquartersKensington, California, United States
Earliest incorporation on record2019
Employees (self-reported, 2022)4
SEC CIK1779315

What does Acrigen Biosciences do?

US government research funding

3 SBIR/STTR small-business research awards from US health agencies, $765,291 in total (2020 to 2022). NIH funding came from the National Institute of General Medical Sciences, National Center for Advancing Translational Sciences.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $775,000 sold (2019).

Frequently asked questions about Acrigen Biosciences

Where is Acrigen Biosciences headquartered?

Acrigen Biosciences, Inc. is headquartered in Kensington, California, United States.

What does Acrigen Biosciences do?

Acrigen Biosciences, Inc. is a biotechnology company.

When was Acrigen Biosciences founded?

The earliest incorporation on record for Acrigen Biosciences, Inc. is in 2019, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences